Search
Menu
Home
HTB
2003
May
HTB
May 2003
Contents
Editorial
Volume 4 Number 4 May 2003
Conference reports
4th International Workshop on Clinical Pharmacology of HIV Therapy, 27-29 March 2003, Cannes, France
Can low NVP plasma concentrations explain the results seen in the EFV and NVP containing arms of the NARVAL study?
Up to one third of patients receiving standard doses of NNRTIs may be being underdosed
Nelfinavir concentrations are significantly higher in HIV/HCV co-infected patients with cirrhosis
Less diarrhoea and bioequivalence with the new nelfinavir 625mg tablet
The potential for probenecid to have a serious interaction with HIV-1 protease inhibitors
PK studies reveal significant sex/gender differences
Pregnancy-related PK studies
New test to measure intracellular levels of nucleosides
Case studies for therapeutic drug monitoring (TDM)
Launch of guide to the use of drug level monitoring
10th Conference on Retroviruses and Opportunistic Infections (CROI), 10-14 February 2003, Boston, USA
Pharmacokinetic papers from 10th CROI
Pediatric studies from 10th CROI
Antiretrovirals
T-20 access programme to continue in UK for a further two months
Durability and success capability of HAART: 4.5 years follow-up
Older HIV-positive patients in the era of HAART: changing of a scenario
Immune reconstitution in older HIV-positive individuals
Treatment access
The City turns up the heat on drug companies to make treatment available in poorest countries
Lancet commentary concludes that prevention and treatment in South Africa are affordable and desirable
South Africa treatment protests go global
Gilead to sell tenofovir at cost to 68 countries
New advocacy coalition demands emergency funding from rich governments for Global Fund
Lipodystrophy and metabolic complications
Statins and fibrates both relatively effective for PI-induced hyperlipidemia
Pioglitazone subjectively improves body shape abnormalities
Hepatitis coinfection
BHIVA HIV/hepatitis B and HIV/hepatitis C co-infection guidelines (2003): posted to web for consultation
Index of biochemical markers could reduce need for biopsy by half in HIV/HCV co-infected patients
HCV protects against abnormal blood lipids in HAART-treated HIV patients
HCV levels in semen
Basic science and immunology
Tissue T-cell analysis represents renewed challenge to ‘tap and drain’ orthodoxy
Drug resistance
Study reveals new reverse transcriptase mutations
Nutrition
Integrating nutrition therapy into medical management of HIV: a supplement of Clinical Infectious Diseases
On the web
38th Annual Meeting of the European Association for the Study of the Liver (EASL)
First European HIV Drug Resistance Workshop
Further Coverage of 10th Retrovirus Conference
Medscape articles
Newsletters and journals: IAPAC Monthly, AIDS Treatment News, STEP Perspective, PRN Notebook, Hopkins HIV Report, GHMC Treatment Issues, TAG Line
Nutritional Care Manual for HIV-positive people
PDFs
Volume 4 Number 4 May 2003 PDF
HTB RSS
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage